DOI QR코드

DOI QR Code

Non-Association of IL-16 rs4778889 T/C Polymorphism with Cancer Risk in Asians: a Meta-analysis

  • Xu, Lin-Lin (Department of Clinical Laboratory, The First People's Hospital of Yancheng) ;
  • Song, Zhi-Chun (Clinical Laboratory of the Sixth Affiliated Hospital of Wenzhou Medical University & Lishui People's Hospital) ;
  • Shang, Kun (Department of Nuclear Medicine, Xuanwu Hospital, Capital Medical University) ;
  • Zhao, Li-Qin (Department of Hematology, The First Affiliated Hospital, University of South China) ;
  • Zhu, Zhan-Sheng (Department of Forensic Medicine, Xuzhou Medical College)
  • Published : 2014.01.30

Abstract

The IL-16 rs4778889 T/C polymorphism is associated with cancer risk. However, the results are conflicting. We performed this meta-analysis to derive a more precise estimation of the relationship. A comprehensive literature search was performed using PubMed, Embase and Web of Science databases. Odds ratio (OR) and 95% confidence interval (CI) were used to assess the strength of association. A total of 6 studies including 1,603 cases and 2,342 controls were identified. With all studies involved, results showed no statistically significant association between IL-16 rs4778889 T/C polymorphism and cancer risk (CC vs. CT+TT: OR=0.74, 95%CI:0.55-1.02, $P_h=0.15$; CC+CT vs. TT: OR=0.89, 95%CI: 0.72-1.10, $P_h=0.03$; CC vs. TT: OR=0.73, 95%CI: 0.53-1.00, $P_h=0.08$; CT vs. TT: OR=0.91, 95%CI: 0.79-1.05, $P_h=0.08$; C vs. T: OR=0.89, 95%CI: 0.74-1.07, $P_h=0.02$). In addition, the results were not changed when studies were stratified by cancer type. However, to verify our findings, it is essential to perform more well-designed studies with larger sample sizes in the future.

Keywords

References

  1. Azimzadeh P, Romani S, Mohebbi SR, et al (2011). Interleukin-16 (IL-16) gene polymorphisms in Iranian patients with colorectal cancer. J Gastrointestin Liver Dis, 20, 371-6.
  2. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  3. Center DM, Kornfeld H, Cruikshank WW (1996). Interleukin 16 and its function as a CD4 ligand. Immunol Today, 17, 476-81. https://doi.org/10.1016/0167-5699(96)10052-I
  4. Chow MT, Moller A, Smyth MJ (2012). Inflammation and immune surveillance in cancer. Semin Cancer Biol, 22, 23-32. https://doi.org/10.1016/j.semcancer.2011.12.004
  5. Cruikshank WW, Center DM, Nisar N, et al (1994). Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci USA, 91, 5109-13. https://doi.org/10.1073/pnas.91.11.5109
  6. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  7. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  8. Gao LB, Liang WB, Xue H, et al (2009). Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. Clin Chim Acta, 409, 132-5. https://doi.org/10.1016/j.cca.2009.09.017
  9. Gao LB, Rao L, Wang YY, et al (2009). The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis, 30, 295-9.
  10. Kim HS (1999). Assignment of human interleukin 16 (IL16) to chromosome 15q26.3 by radiation hybrid mapping. Cytogenet Cell Genet, 84, 93. https://doi.org/10.1159/000015224
  11. Kundu JK, Surh YJ (2012). Emerging avenues linking inflammation and cancer. Free Radic Biol Med, 52, 2013-37. https://doi.org/10.1016/j.freeradbiomed.2012.02.035
  12. Li S, Deng Y, Chen ZP, et al (2011). Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Infect Genet Evol, 11, 2083-8. https://doi.org/10.1016/j.meegid.2011.09.025
  13. Mathy NL, Scheuer W, Lanzendorfer M, et al (2000). Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology, 100, 63-9. https://doi.org/10.1046/j.1365-2567.2000.00997.x
  14. Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004). Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer, 4, 850-60. https://doi.org/10.1038/nrc1476
  15. Zhu J, Qin C, Yan F, et al (2010). IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population. Int J Urol, 17, 700-7. https://doi.org/10.1111/j.1442-2042.2010.02559.x

Cited by

  1. Association of genetic polymorphisms of interleukins with gastric cancer and precancerous gastric lesions in a high-risk Chinese population vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-4022-x